Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilario Navarro

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Bioinformatics|December 16, 2011
A new method for identifying bivariate differential expression in high dimensional microarray data using quadratic discriminant analysisJorge M Arevalillo, Hilario Navarro
Computers in Biology and Medicine|September 17, 2013
Exploring correlations in gene expression microarray data for maximum predictive-minimum redundancy biomarker selection and classificationJorge M Arevalillo, Hilario Navarro
Oncotarget|July 3, 2018
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancerAndrea Zapater-Moros, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
BMC Cancer|June 30, 2019
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunitiesLucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
Cancer Research|April 18, 2015
Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical ImplicationsAngelo Gámez-Pozo, Julia Berges-Soria, Jorge M Arevalillo, et al.
BMC Cancer|April 16, 2020
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancerLucía Trilla-Fuertes, Angelo Gámez-Pozo, Elena López-Camacho, et al.
Scientific Reports|February 9, 2019
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognosesGuillermo Prado-Vázquez, Angelo Gámez-Pozo, Lucía Trilla-Fuertes, et al.
Plos One|June 12, 2020
Bayesian networks established functional differences between breast cancer subtypesLucía Trilla-Fuertes, Angelo Gámez-Pozo, Jorge M Arevalillo, et al.
Scientific Reports|November 19, 2017
Urothelial cancer proteomics provides both prognostic and functional informationGuillermo de Velasco, Lucia Trilla-Fuertes, Angelo Gamez-Pozo, et al.
Oncotarget|March 9, 2018
Molecular characterization of breast cancer cell response to metabolic drugsLucía Trilla-Fuertes, Angelo Gámez-Pozo, Jorge M Arevalillo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Bioinformatics|December 16, 2011
A new method for identifying bivariate differential expression in high dimensional microarray data using quadratic discriminant analysisJorge M Arevalillo, Hilario Navarro
Computers in Biology and Medicine|September 17, 2013
Exploring correlations in gene expression microarray data for maximum predictive-minimum redundancy biomarker selection and classificationJorge M Arevalillo, Hilario Navarro
Oncotarget|July 3, 2018
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancerAndrea Zapater-Moros, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
BMC Cancer|June 30, 2019
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunitiesLucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
Cancer Research|April 18, 2015
Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical ImplicationsAngelo Gámez-Pozo, Julia Berges-Soria, Jorge M Arevalillo, et al.
BMC Cancer|April 16, 2020
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancerLucía Trilla-Fuertes, Angelo Gámez-Pozo, Elena López-Camacho, et al.
Scientific Reports|February 9, 2019
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognosesGuillermo Prado-Vázquez, Angelo Gámez-Pozo, Lucía Trilla-Fuertes, et al.
Plos One|June 12, 2020
Bayesian networks established functional differences between breast cancer subtypesLucía Trilla-Fuertes, Angelo Gámez-Pozo, Jorge M Arevalillo, et al.
Scientific Reports|November 19, 2017
Urothelial cancer proteomics provides both prognostic and functional informationGuillermo de Velasco, Lucia Trilla-Fuertes, Angelo Gamez-Pozo, et al.
Oncotarget|March 9, 2018
Molecular characterization of breast cancer cell response to metabolic drugsLucía Trilla-Fuertes, Angelo Gámez-Pozo, Jorge M Arevalillo, et al.
Pageof 2